[1]
A. T. Moura, F. Duarte, M. Barbosa, T. Santos, and R. Lemes, “Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil”, Clinics, vol. 74, p. e771, May 2019.